Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report

TAKAHIRO HIRAI; MINEHIKO INOMATA; SHUHEI MINATOYAMA; MOE HASHIZUME; NAOKI TAKATA; KANA HAYASHI; ZENTA SETO; KOTARO TOKUI; CHIHIRO TAKA; SEISUKE OKAZAWA; KENTA KAMBARA; SHINGO IMANISHI; TOSHIRO MIWA; RYUJI HAYASHI; SHINICHI TANAKA; AKIRA NOGUCHI; TSUTOMU SATO

doi:10.21873/invivo.13599

Article Information

vol. 38 no. 3 1509-1511

DOI

https://doi.org/10.21873/invivo.13599

PMID

38688637

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received February 8, 2024
Revision received March 7, 2024
Accepted March 8, 2024
Published online April 30, 2024.

Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

TAKAHIRO HIRAI¹,
MINEHIKO INOMATA¹ ⇑,
SHUHEI MINATOYAMA¹,
MOE HASHIZUME¹,
NAOKI TAKATA¹,
KANA HAYASHI¹,
ZENTA SETO¹,
KOTARO TOKUI¹,
CHIHIRO TAKA¹,
SEISUKE OKAZAWA¹,
KENTA KAMBARA¹,
SHINGO IMANISHI¹,
TOSHIRO MIWA¹,
RYUJI HAYASHI²,
SHINICHI TANAKA³,
AKIRA NOGUCHI³ and
TSUTOMU SATO⁴

¹First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan;
²Department of Medical Oncology, Toyama University Hospital, Toyama, Japan;
³Department of Diagnostic Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan;
⁴Department of Hematology, Toyama University Hospital, Toyama, Japan

Correspondence to: Minehiko Inomata, MD, Ph.D., First Department of Internal Medicine, Toyama University Hospital, 2630 Sugitani, Toyama 930-0194, Japan. Tel: +81 764347287, Fax: +81 764345025, e-mail: 9446-tym{at}umin.org

View Full Text